Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
CNP inhibits vascular ACE; leaves open its physiological role and therapeutic potential in vascular disease.
Conference Abstract| July 01 1995 C-Type Natriuretic Peptide: An Endogenous Inhibitor of Vascular Angiotensin-Converting Enzyme Activity NC Davidson; NC Davidson 1Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee DD1 9SY Search for other works by this author on: This Site PubMed Google Scholar CS Barr; CS Barr 1Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee DD1 9SY Search for other works by this author on: This Site PubMed Google Scholar AD Struthers AD Struthers 1Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee DD1 9SY Search for other works by this author on: This Site PubMed Google Scholar Clin Sci (Lond) (1995) 89 (s33): 2P–3P. https://doi.org/10.1042/cs089002Pc Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter LinkedIn Cite Icon Cite Get Permissions Citation NC Davidson, CS Barr, AD Struthers; C-Type Natriuretic Peptide: An Endogenous Inhibitor of Vascular Angiotensin-Converting Enzyme Activity. Clin Sci (Lond) 1 July 1995; 89 (s33): 2P–3P. doi: https://doi.org/10.1042/cs089002Pc Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu nav search search input Search input auto suggest search filter All ContentAll JournalsClinical Science Search Advanced Search This content is only available as a PDF.
No takes yet. Share an insight, caveat, or question.
Davidson et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: